Inactive Instrument
Company Guided Therapeutics Inc OTC Bulletin Board
Stocks
US40171F1057
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 06-16 | Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA | CI |
| 05-15 | Guided Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Business description: Guided Therapeutics Inc

Sales by Activity: Guided Therapeutics Inc
| Fiscal Period: December | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
Developing Innovative Medical Devices | 81K | 13K | 98K | 7K | 767K |
Executive Committee: Guided Therapeutics Inc
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 70 | 2023-03-05 |
| Chief Tech/Sci/R&D Officer | 70 | 2010-12-01 |
Composition of the Board of Directors: Guided Therapeutics Inc
| Director | Title | Age | Since |
|---|---|---|---|
Mark Faupel
BRD | Director/Board Member | 70 | 2016-11-30 |
John Imhoff
BRD | Director/Board Member | 76 | 2006-04-09 |
Michael James
CHM | Chairman | 67 | 2013-09-30 |
Richard Blumberg
BRD | Director/Board Member | 69 | 2016-11-09 |
Alan Grujic
BRD | Director/Board Member | 58 | 2023-03-07 |
Company details: Guided Therapeutics Inc
Guided Therapeutics, Inc.
5835 Peachtree Corners East
30092, Peachtree Corners
+770 242 8723
http://www.guidedinc.com
Other Advanced Medical Equipment & Technology
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.97% | +2.03% | +21.92% | +0.83% | 195B | ||
| +5.87% | +5.27% | -21.76% | +26.78% | 151B | ||
| +2.17% | +0.89% | -2.59% | -16.42% | 140B | ||
| +4.83% | +2.06% | -56.73% | -15.69% | 67.09B | ||
| +2.59% | +3.95% | +22.89% | +3.15% | 54.34B | ||
| +0.03% | +2.19% | -25.48% | -31.00% | 44.64B | ||
| -2.02% | -3.91% | +7.67% | +9.53% | 36.91B | ||
| +0.31% | +1.30% | +8.30% | +43.25% | 37.24B | ||
| +1.09% | -0.30% | -13.81% | -18.74% | 29.82B | ||
| Average | +1.87% | +2.23% | -6.62% | +0.19% | 83.95B | |
| Weighted average by Cap. | +2.66% | +3.26% | -3.84% | +1.38% |
- Stock Market
- Stocks
- GTHP Stock
- Stock
- Company Guided Therapeutics Inc
Select your edition
All financial news and data tailored to specific country editions

















